|12 Months Ended|
Aug. 31, 2022
20. Subsequent Events
On September 2, 2022, Catherine Turkel, PharmD, PhD was appointed to our Board and was awarded 3,400 options at a strike price of $3.04, vesting immediately with a 5 year term and a value of $7,757 using the Black Scholes pricing model.
Subsequent to the year ended August 31, 2022, the Company issued 41,200 stock options to the Company’s independent directors at a strike price of $1.96, vesting immediately with a 5 year term and a value of $61,109 using the Black Scholes pricing model.
On November 5, 2022, 7,500 warrants with a strike price of $24.00 expired.
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef